Is CVAC or JNJ a better dividend investment in 2026?

CVAC currently yields 42.92% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CVAC offers higher current income.

What is the dividend yield difference between CVAC and JNJ?

CVAC has a forward dividend yield of 42.92% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 39.56 percentage points.

Home › Compare › CVAC vs JNJ

CVAC vs JNJ: Dividend Comparison 2026

CVAC yields 42.92% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CVAC wins by $251.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CVAC

● Live price

42.92%

Share price

$4.66

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$271.5K

Annual income

$48,622.47

Full CVAC calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CVAC vs JNJ

📍 CVAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CVAC	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CVAC + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CVAC pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVAC

Annual income on $10K today (after 15% tax)

$3,648.07/yr

After 10yr DRIP, annual income (after tax)

$41,329.10/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, CVAC beats the other by $40,625.49/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVAC + JNJ for your $10,000?

CVAC: 50%JNJ: 50%

100% JNJ50/50100% CVAC

Portfolio after 10yr

$145.8K

Annual income

$24,725.12/yr

Blended yield

16.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CVAC

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$21.00

+350.6% upside vs current

Range: $5.00 — $37.00

Altman Z

1.7

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVAC buys

JNJ buys

No recent congressional trades found for CVAC or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCVACJNJ

Forward yield	42.92% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$271.5K ✓	$20.0K
Annual income after 10y	$48,622.47 ✓	$827.78
Total dividends collected	$208.4K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy
Analyst price target	$21.00	$228.73 ✓

Year-by-year: CVAC vs JNJ ($10,000, DRIP)

Year	CVAC Portfolio	CVAC Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$14,992	$4,291.85	$10,676	$355.77	+$4.3K → CVAC
2	$22,055	$6,013.34	$11,407	$389.39	+$10.6K → CVAC
3	$31,866	$8,267.53	$12,198	$426.53	+$19.7K → CVAC
4	$45,261	$11,164.00	$13,056	$467.62	+$32.2K → CVAC
5	$63,248	$14,819.35	$13,987	$513.12	+$49.3K → CVAC
6	$87,030	$19,354.11	$14,998	$563.56	+$72.0K → CVAC
7	$118,011	$24,889.07	$16,098	$619.52	+$101.9K → CVAC
8	$157,813	$31,541.28	$17,295	$681.69	+$140.5K → CVAC
9	$208,280	$39,419.96	$18,599	$750.82	+$189.7K → CVAC
10	$271,482	$48,622.47	$20,022	$827.78	+$251.5K → CVAC

CVAC vs JNJ: Complete Analysis 2026

CVAC — Stock

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

Full CVAC Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CVAC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVAC vs SCHD CVAC vs JEPI CVAC vs O CVAC vs KO CVAC vs MAIN CVAC vs ABBV CVAC vs MRK CVAC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.